Marker Therapeutics Inc (MRKR)
3.10
+0.15
(+5.02%)
USD |
NASDAQ |
Nov 22, 16:00
3.22
+0.12
(+3.87%)
After-Hours: 20:00
Marker Therapeutics Total Assets (Quarterly): 10.91M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 10.91M |
June 30, 2024 | 11.68M |
March 31, 2024 | 14.09M |
December 31, 2023 | 17.13M |
September 30, 2023 | 19.49M |
June 30, 2023 | 21.96M |
March 31, 2023 | 27.94M |
December 31, 2022 | 34.42M |
September 30, 2022 | 41.11M |
June 30, 2022 | 52.32M |
March 31, 2022 | 54.96M |
December 31, 2021 | 68.14M |
September 30, 2021 | 71.94M |
June 30, 2021 | 80.47M |
March 31, 2021 | 88.36M |
December 31, 2020 | 45.61M |
September 30, 2020 | 48.57M |
June 30, 2020 | 48.52M |
March 31, 2020 | 42.89M |
December 31, 2019 | 46.36M |
September 30, 2019 | 51.40M |
June 30, 2019 | 55.00M |
March 31, 2019 | 58.99M |
December 31, 2018 | 62.14M |
September 30, 2018 | 4.391M |
Date | Value |
---|---|
June 30, 2018 | 7.892M |
March 31, 2018 | 2.930M |
December 31, 2017 | 5.180M |
September 30, 2017 | 7.704M |
June 30, 2017 | 10.14M |
March 31, 2017 | 6.105M |
December 31, 2016 | 7.921M |
September 30, 2016 | 9.698M |
June 30, 2016 | 3.789M |
March 31, 2016 | 5.759M |
December 31, 2015 | 6.645M |
September 30, 2015 | 6.225M |
June 30, 2015 | 3.248M |
March 31, 2015 | 1.536M |
December 31, 2014 | 0.2244M |
September 30, 2014 | 0.6436M |
June 30, 2014 | 0.0357M |
March 31, 2014 | 0.1094M |
December 31, 2013 | 0.077M |
September 30, 2013 | 0.15M |
June 30, 2013 | 0.1853M |
March 31, 2013 | 0.1514M |
December 31, 2012 | 0.0874M |
September 30, 2012 | 0.0607M |
June 30, 2012 | 0.0642M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.91M
Minimum
Sep 2024
88.36M
Maximum
Mar 2021
42.34M
Average
44.25M
Median
Total Assets (Quarterly) Benchmarks
AIM ImmunoTech Inc | 13.59M |
Perspective Therapeutics Inc | 391.15M |
Protalix BioTherapeutics Inc | 61.56M |
Electromed Inc | 48.92M |
Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.461M |
Shareholders Equity (Quarterly) | 7.450M |